FDA Approves Omisirge Cell Therapy For Blood Cancers

The U.S. Food and Drug Administration approved Gamida Cell Ltd.’s Omisirge (omidubicel-onlv) cell therapy for patients with blood cancers to reduce risk of infection following stem cell transplantation. Gamida Cell shares gained around 39 percent on Monday’s regular trading. The gain continued in the after hours trading with a further […]

» Read more

U.S. Stocks Look Headed For Flat Close

U.S. stocks look headed for a flat close on Monday with investors largely making cautious moves as they await earnings updates from banks and economic data, for more clarity about the state of the nation’s economy. The major averages are all down in negative territory, though with marginal losses. The […]

» Read more

27 Nations Driving Up Record Global Military Spending

World military spending increased by 3.7% in 2022, according to a report from the Stockholm International Peace Research Institute released today. The arms control and disarmament research organization noted that by far the largest driver of the global increase was the escalation of tensions in Europe, the result of Russia’s […]

» Read more
1 53 54 55 56 57 523